文献速递睡眠呼吸障碍

阻塞性睡眠呼吸暂停的个体化管理策略

Personalized Management Approach for OSA.
PubMed 文献 · Chest · 2017-06-16

本文为综述,指出OSA是异质性疾病,咽部解剖异常与多种非解剖表型特征共同致病,而现有疗法多仅针对解剖因素。呼吸表型分析技术识别出可治疗特征,据此选择性靶向治疗有望实现精准医学下的个体化管理并改善结局。

要点

  • OSA为异质性疾病,非解剖表型特征在多数患者中同样重要
  • 现有疗法多仅针对解剖病因,且多以单一疗法试错式使用
  • 呼吸表型分析识别的可治疗特征可指导个体化治疗选择

核心结论

  • OSA是异质性疾病,识别可治疗特征并开发选择性靶向疗法,有望按精准医学原则实现个体化管理以优化患者结局。

研究设计与样本

  • 综述,总结OSA个体化管理的最新进展与新兴疗法;未在摘要中报告检索范围与样本量。

主要发现

  • 多数患者除咽部解剖异常(气道狭窄/易塌陷)外,非解剖表型特征亦是重要致病因素。
  • 现有疗法(如CPAP、口腔矫治器、减重、体位治疗、上气道手术)仅针对解剖病因。
  • 现有疗法通常按试错方式作为单一疗法使用,多数患者首先处方CPAP。
  • CPAP虽高效但依从性仍低得不可接受,二线疗法疗效多变且难以预测。
  • 呼吸表型分析技术识别出新的治疗靶点或可治疗特征以指导治疗。

关键数值与推荐

  • 原文未报告具体数值、比例、阈值、剂量、样本量或P值。

临床怎么用

  • 临床上可考虑以呼吸表型分析识别可治疗特征,据此选择或联合针对性疗法,而非仅依赖针对解剖因素的单一疗法。

局限性

  • 本文为简短综述,摘要未报告检索策略、纳入研究数量及证据等级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OSA is a heterogeneous disorder. If left untreated, it has major health, safety, and economic consequences. In addition to varying levels of impairment in pharyngeal anatomy (narrow/collapsible airway), nonanatomical "phenotypic traits" are also important contributors to OSA for most patients. However, the majority of existing therapies (eg, CPAP, oral appliances, weight loss, positional therapy, upper airway surgery) target only the anatomical cause. These are typically administered as monotherapy according to a trial and error management approach in which the majority of patients are first prescribed CPAP. Despite its high efficacy, CPAP adherence remains unacceptably low, and second-line therapies have variable and unpredictable efficacies. Recent advances in knowledge regarding the multiple causes of OSA using respiratory phenotyping techniques have identified new targets or "treatable traits" to direct therapy. Identification of the traits and development of therapies that selectively target one or more of the treatable traits has the potential to personalize the management of this chronic health condition to optimize patient outcomes according to precision medicine principles. This brief review highlights the latest developments and emerging therapies for personalized management approaches for OSA.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Carberry JC, Amatoury J, Eckert DJ, et al. Personalized Management Approach for OSA. Chest. 2017. PMID: 28629917. doi:10.1016/j.chest.2017.06.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。